Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aldeyra Therapeu (NQ: ALDX )

8.810 USD +0.180 (+2.09%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 27, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 555,677
Open 8.600
Bid (Size) 8.770 (1)
Ask (Size) 9.550 (8)
Prev. Close 8.630
Today's Range 8.480 - 9.090
52wk Range 5.530 - 15.95
Shares Outstanding 57,631,203
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Aldeyra Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for ADX-2191 to Treat Primary Vitreoretinal Lymphoma
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company for ADX-2191 (methotrexate for... 
From Business Wire News Releases
Aldeyra Therapeutics Joins the Russell 2000® and Russell 3000® Indexes
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company developing novel immune-modulating therapies to treat ocular and systemic diseases, today announced that the company was... 
From Business Wire News Releases

Performance

YTD
+34.92%
+34.92%
1 Month
-26.09%
-26.09%
3 Month
-20.70%
-20.70%
6 Month
-27.13%
-27.13%
1 Year
+30.13%
+30.13%

More News

Read More
Aldeyra Therapeutics to Participate in Fireside Chat at the Jefferies Virtual Healthcare Conference
From Business Wire News Releases
Aldeyra Stock Trading Higher On FDA Orphan Drug Tag For Primary Vitreoretinal Lymphoma Candidate
Tags Orphan Drug Designation Small Cap Biotech
From Benzinga
Thinking about buying stock in Immunome, Aldeyra Therapeutics, New Oriental Education, ConforMIS, or Cytokinetics?
From PR Newswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Tags ALDX Pre/Market Outlook LOGC
From Benzinga
Aldeyra Therapeutics Reports First-Quarter 2021 Financial Results and Recent Business Highlights
From Business Wire News Releases
Interesting ALDX Put And Call Options For March 2022
Tags Stocks
From Market News Video
First Week of August 20th Options Trading For Aldeyra Therapeutics (ALDX)
Tags Stocks
From Market News Video
Analysts Expect XBI Will Reach $216
Tags ETFs
From ETF Channel
Aldeyra Therapeutics Schedules Webcast and Conference Call to Report First-Quarter 2021 Financial Results and Discuss Recent Business Highlights
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.